Immune Design Corp.·4

Jan 6, 9:05 PM ET

Immune Design Corp. 4

4 · Immune Design Corp. · Filed Jan 6, 2017

Insider Transaction Report

Form 4
Period: 2017-01-04
PENHOET EDWARD
Director10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2017-01-04+10,00010,000 total
    Exercise: $5.60Exp: 2027-01-04Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]The shares underlying the option will become fully vested on January 4, 2018, subject to the Reporting Person's continuous service through such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION